The Cancer Letter

Inside information on cancer research and drug development

Vol.
31
No.
2
January 14, 2005Jan 14, 2005
Free
DOWNLOAD THE PDF

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

Also in This 8-page Issue: NCI Seeks $6.17 Billion in “Bypass” Budget Request, But Faces Shortfall In Its Actual Budget.

NCI Names 15 to Director’s Consumer Liaison Group.

SAIC-Frederick Makes Awards To Proteomics Research Teams.

Latest State Cancer Statistics Released.

Smokers May Get Cessation Help From Medicare.

Funding Opportunities Listed.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account